166 filings
Page 3 of 9
6-K
VALN
Valneva SE
31 Mar 23
Current report (foreign)
4:05pm
20-F
2022 FY
VALN
Valneva SE
Annual report (foreign)
30 Mar 23
4:06pm
6-K
VALN
Valneva SE
23 Mar 23
Valneva Reports Full Year 2022 Results and Provides Corporate Updates
3:09pm
6-K
VALN
Valneva SE
2 Mar 23
Valneva Provides Clinical and Regulatory Updates for its COVID-19 Vaccine VLA2001
5:30pm
6-K
VALN
Valneva SE
21 Feb 23
Current report (foreign)
6:10am
6-K
VALN
Valneva SE
17 Feb 23
Pfizer and Valneva Issue Update on Phase 3 Clinical Trial Evaluating Lyme Disease Vaccine Candidate VLA15
5:30pm
6-K
VALN
Valneva SE
16 Feb 23
Valneva Completes Enrollment for Adolescent Phase 3 Trial of Single-Shot Chikungunya Vaccine Candidate
8:33am
6-K
VALN
Valneva SE
3 Jan 23
Valneva Reports Further Heterologous Booster Data for its inactivated COVID-19 vaccine
11:33am
6-K
VALN
Valneva SE
23 Dec 22
Valneva to Conduct Investor Meetings during the J.P. Morgan Healthcare Conference and Oddo BHF Forum
8:21am
6-K
VALN
Valneva SE
6 Dec 22
Valneva Reports Positive 12-Month Antibody Persistence Data for Single-Shot Chikungunya Vaccine Candidate
5:30pm
6-K
VALN
Valneva SE
1 Dec 22
Valneva to Host Investor Day in New York City
6:05am
6-K
VALN
Valneva SE
17 Nov 22
Valneva Appoints Dipal Patel as Chief Commercial Officer
2:05pm
SC 13D
VALN
Valneva SE
16 Nov 22
Valneva SE / Bpifrance Participations ownership change
9:59am
6-K
VALN
Valneva SE
10 Nov 22
Valneva Reports Nine-Month 2022 Results and Provides Corporate Updates
11:05am
6-K
VALN
Valneva SE
8 Nov 22
Valneva to Present and Hold Investor Meetings at the Jefferies London Healthcare Conference
10:48am
6-K
VALN
Valneva SE
11 Oct 22
Valneva to Present on its Single-Shot Chikungunya Vaccine Candidate at Leading Scientific Conferences
12:37pm
SC 13G
Deep Track Capital, LP
7 Oct 22
Valneva SE / Deep Track Capital ownership change
4:02pm
6-K
VALN
Valneva SE
6 Oct 22
Valneva Announces Closing of Upsized €102.9 Million Global Offering
6:02am
6-K
VALN
Valneva SE
30 Sep 22
Valneva Announces the Pricing of €102.9 Million Global Offering of American Depositary Shares and Ordinary Shares
4:22pm
424B5
VALN
Valneva SE
30 Sep 22
Prospectus supplement for primary offering
4:09pm